Rainbow secures a dominating share in Pratiksha Hospital based in Guwahati

In a significant move for adult healthcare in India, Pfizer has launched the Pneumococcal Conjugate vaccine. This vaccine, designed specifically for adults, aims to combat pneumococcal diseases, a leading cause of illness and death worldwide.

The Department for Promotion of Industry and Internal Trade (DPIIT) has signed a Memorandum of Understanding (MoU) with Pfizer. This collaboration aims to accelerate the lab-to-market journey of healthcare products, potentially paving the way for more innovative solutions in the Indian healthcare sector.

Meanwhile, Medanta has expanded its chemotherapy day care services, providing expanded access to essential cancer treatments in South Delhi.

On a global scale, the World Health Organization (WHO) has made significant updates to its Essential Medicines List (EML). The WHO has added GLP-1 receptor agonists and rapid-acting insulin analogues to the list. These additions are expected to improve the management of diabetes and other related conditions.

In another development, ShardaCare Healthcity and Sharda Hospital have appointed Sandeep Dogra as their Group COO. This appointment marks a new era for these healthcare institutions, as Dogra brings a wealth of experience and expertise to his role.

Regarding the role of robotics in kidney-preserving cancer care, recent discussions have highlighted its potential benefits. However, no new standalone facts were provided in the current paragraph.

The launch of the Pneumococcal Conjugate vaccine by Pfizer marks a significant step forward in the fight against pneumococcal diseases in India. The expanded chemotherapy day care services by Medanta and the updates to the WHO's Essential Medicines List are also noteworthy developments in the global healthcare landscape. The appointment of Sandeep Dogra as Group COO of ShardaCare Healthcity and Sharda Hospital is expected to bring about positive changes in these institutions.